ASSET PURCHASE AGREEMENT BY AND BETWEEN 2SEVENTY BIO, INC. AND REGENERON PHARMACEUTICALS, INC. DATED AS OF January 29, 2024Asset Purchase Agreement • May 9th, 2024 • 2seventy Bio, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 9th, 2024 Company Industry JurisdictionTHIS ASSET PURCHASE AGREEMENT (this “Agreement”), dated as of January 29, 2024, is made by and between 2seventy bio, Inc., a Delaware corporation (“Seller”), and Regeneron Pharmaceuticals, Inc., a New York corporation (“Buyer”).